Skip to main content
Clinical Trials/NCT05962203
NCT05962203
Not Yet Recruiting
N/A

SHIP-AGE: Frailty, Renal Function, and Multi-component Primary Care in Rural Mecklenburg-Western Pomerania.

University Medicine Greifswald0 sites820 target enrollmentSeptember 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Frailty Syndrome
Sponsor
University Medicine Greifswald
Enrollment
820
Primary Endpoint
body weight loss
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Chronic kidney disease (CKD) is a leading risk factor for cardiovascular and all-cause mortality among the elderly. Mecklenburg-Western Pomerania has the largest prevalence of CKD in Germany and Europe. The CKD impact in primary care strategies to reduce frailty syndrome in the elderly is unknown. For this purpose, about 820 elderly participants will be included in an observational study (MV-FIT), who will undergo an multi-factorial geriatric assessment, monitoring & management program, specifically designed to avoid frailty. The goal of the full-scale study is to evaluate the impact of CKD in multi-component primary care strategies to reduce frailty among elderly persons in rural Mecklenburg-Western Pomerania. MV-FIT will be conducted on individuals in rural Mecklenburg-Western Pomerania, who will be observed over a period of 3 years. The Study of Health in Pomerania (SHIP) is a population-based epidemiological, two independent-cohort, study (SHIP and SHIP-TREND). SHIP cohorts have been followed for >24 years. SHIP/SHIP TEND participants >60 years or older will studied by a follow-up survey. The aim is to gain new insights into the development of frailty and to develop strategies for keeping those affected healthy.

Detailed Description

Our study is a longitudinal population-based epidemiological SHIP-cohort study combined with a prospective, multi-centered, observational/interventional investigation. MV-FIT is an observational study of individuals aged 65 years or older with mGFR \>30 mL/min (n=\~820). All participants in the observational/interventional study will receive guideline-based, multi-factorial geriatric assessment, monitoring \& managements (multi-component healthcare). Subjects will be stratified by mGFR. Objectives are 1) to implement multi-component healthcare specifically comprised of components to reduce frailty and incident falls, 2) to improve compliance and adherence to the multi-component healthcare for frailty and improvement of patient welfare, ability to live independently, quality-of-life, number of falls, referrals to nursing homes, all-cause mortality in primary care of the elderly, 3) to seek the elderly individuals' experience during the course of multi-factorial primary care intervention through In-depth interviews, 4) to clarify the burden of CKD on frailty and health status, and 5) to identify novel risk factors and mechanisms for frailty and pre-frailty. MV-FIT data will be corroborated by SHIP/SHIP-TREND data.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
December 31, 2029
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Medicine Greifswald
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age 65 years or older
  • mGFR \> 30 mL/min per 1.73 m2
  • being able to understand and give written informed consent.

Exclusion Criteria

  • bedridden
  • palliative
  • inability to consent
  • severe dementia
  • inability to speak
  • lack of compliance (paracusis, inability to fulfill at least 60% of the assessments)

Outcomes

Primary Outcomes

body weight loss

Time Frame: 36 months

unintentional body weight loss (determined weight in kilograms); see phenotype criteria (# 1) above

Frailty

Time Frame: from baseline to follow-up at 36 month

The primary outcome will be frailty from baseline to follow-up at 36 months post subject inclusion (i.e. Frail vs. non-Frail). The frailty phenotype defines frailty as a clinical syndrome meeting three or more of five phenotypic criteria: (1) unintentional body weight loss (2) slow walking pace, (3) self-reported exhaustion, (4) muscle weakness, and (5) self-reported low physical activity.

slow walking pace

Time Frame: 36 months

slow walking pace (determined by walking speed measurements in m/sec); see phenotype criteria (# 2) above

muscle weakness

Time Frame: 36 months

muscle weakness (determined by handgrip and jump strengths in kg); see phenotype criteria (# 4) above

exhaustion

Time Frame: 36 months

self-reported exhaustion (determined by questionnaire), see phenotype criteria (# 3) above

low physical activity

Time Frame: 36 months

(5) self-reported low physical activity (determinded by questionnaire); see phenotype criteria (# 5) above

Secondary Outcomes

  • admission to hospitals(36 months)
  • ability to live independently(36 months)
  • Frailty transition(36 months)
  • mGFR transition(36 months)
  • patient welfare(36 months)
  • number of falls(36 months)
  • referrals to nursing homes(36 months)
  • cognitive decline(36 months)
  • mortality(36 months)

Similar Trials